Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Brazil Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20041
20051
200613
20074
20081
20093
20103
20112
20122
20135
20143
20166
20176
20185
20201
20222
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated7
Unknown status3
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S22
Takeda9
Eli Lilly and Company8
AstraZeneca7
Pfizer5
Allergan3
University of Sao Paulo General Hospital3
Bristol-Myers Squibb2
University of Sao Paulo2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus68
Diabetes Mellitus, Type 243
Glucose Metabolism Disorders13
Dyslipidemias8
Diabetes Mellitus, Type 16
Metabolic Diseases6
Endocrine System Diseases5
Gastroparesis3
Hypertension3
Acute Coronary Syndrome2

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.